Provided by Tiger Trade Technology Pte. Ltd.

Capricor Therapeutics

8.36
+0.06000.72%
Volume:516.47K
Turnover:4.34M
Market Cap:486.04M
PE:-3.39
High:8.57
Open:8.32
Low:8.28
Close:8.30
52wk High:40.37
52wk Low:2.96
Shares:58.14M
Float Shares:45.54M
Volume Ratio:0.84
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4659
EPS(LYR):-2.2601
ROE:-73.70%
ROA:-33.63%
PB:1.97
PE(LYR):-3.70

Loading ...

Sector Update: Healthcare Stocks Flat to Lower Pre-Bell Friday

MT Newswires Live
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS), Cabaletta Bio (CABA) and Capricor Therapeutics (CAPR)

TIPRANKS
·
Aug 14

U.S. Stocks on the MOVE-Reddit, Capricor Therapeutics, Birkenstock

Reuters
·
Aug 14

Cantor Fitzgerald Upgrades Capricor Therapeutics to Overweight From Neutral, Adjusts PT to $28 From $3.50

MT Newswires Live
·
Aug 14

Top Premarket Gainers

MT Newswires Live
·
Aug 14

Capricor Shares Skyrocket as FDA Agrees to Review New Duchenne Drug Data

Reuters
·
Aug 14

Capricor Therapeutics Shares up 105.9% Premarket After FDA Agrees to Review New Duchenne Drug Data

THOMSON REUTERS
·
Aug 14

Capricor Therapeutics Raised to Overweight from Neutral by Cantor Fitzgerald

Dow Jones
·
Aug 14

Capricor Therapeutics (CAPR) Shares Soar Over 67% After Hours: Here's Why

Benzinga Earnings
·
Aug 14

Capricor Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Capricor Therapeutics Q2 EPS $(0.70) Misses $(0.58) Estimate

Benzinga Earnings
·
Aug 14

Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 14

U.S. Earnings Preview: After Market Close Aug. 13

Dow Jones
·
Aug 14

Capricor Therapeutics Lawsuit Focuses on Deramiocel Disclosures After CAPR Stock Drops

TIPRANKS
·
Aug 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

Capricor Therapeutics, Inc. Expected to Post a Loss of 59 Cents a Share - Earnings Preview

Reuters
·
Aug 12

Capricor Therapeutics Updates Financial Calendar with Q2 Results Release, Conference Call and Webcast Scheduled

Reuters
·
Aug 10

Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13

THOMSON REUTERS
·
Aug 10

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

TIPRANKS
·
Aug 01

B. Riley Adjusts Capricor Therapeutics Price Target to $5 From $10, Maintains Neutral Rating

MT Newswires Live
·
Jul 31